Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE) - Intellia Therapeutics

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPZGs5aWdBeGp3ZjdMc3…; target="_blank">Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)</a>&nbsp;&nbsp;<font color="#6f6f6f">Intellia Therapeutics</font>